Literature DB >> 29307363

Brain metastasis: clinical manifestations, symptom management, and palliative care.

Thomas Noh1, Tobias Walbert2.   

Abstract

Patients who have brain metastases can suffer from a medley of symptoms, including headaches, seizures, cognitive impairment, fatigue, and focal deficits. As therapies have evolved, so has the management of these symptoms as patients survive longer. This chapter focuses on the clinical presentation of brain metastases, the treatment of those symptoms, and palliation in end-of-life management. Brain metastases are the most common cerebral malignancy. They can present with various symptoms, which can have significant impact on patients' quality of life throughout the course of their disease. Most of these symptoms are related to direct brain compression from the tumor or from edema. The location of the metastases will determine the focal deficits incurred and most patients will be on a course of steroids tapered according to their clinical status. The chapter includes a list of potential side-effects and considerations for management. Palliative care is an essential and important part of approaching patients with metastases. Early and clear communication about end-of-life decision making is encouraged with multiple easily accessible tools. For patients near the end of life, comfort is the ultimate goal in providing a good quality of life.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  brain metastases; end of life; fatigue; headache; palliative therapy; steroid; symptoms

Mesh:

Year:  2018        PMID: 29307363     DOI: 10.1016/B978-0-12-811161-1.00006-2

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  14 in total

1.  Neurosurgical patients admitted via the emergency department initiating comfort care measures: a prospective cohort analysis.

Authors:  Joseph R Linzey; Rachel Foshee; Sudharsan Srinivasan; Arjun R Adapa; Meghan L Wind; Carina Brake; Badih Junior Daou; Kyle Sheehan; Thomas C Schermerhorn; Teresa L Jacobs; Aditya S Pandey
Journal:  Acta Neurochir (Wien)       Date:  2020-08-21       Impact factor: 2.216

2.  18F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study.

Authors:  Pieter H Nienhuis; Inês F Antunes; Andor W J M Glaudemans; Mathilde Jalving; David Leung; Walter Noordzij; Riemer H J A Slart; Erik F J de Vries; Geke A P Hospers
Journal:  J Nucl Med       Date:  2021-09-09       Impact factor: 11.082

Review 3.  Brain metastases: An update on the multi-disciplinary approach of clinical management.

Authors:  D K Mitchell; H J Kwon; P A Kubica; W X Huff; R O'Regan; M Dey
Journal:  Neurochirurgie       Date:  2021-04-14       Impact factor: 1.553

4.  Seizures Among Patients with Brain Metastases: A Population- and Institutional-level Analysis.

Authors:  Nayan Lamba; Paul J Catalano; Daniel N Cagney; Daphne A Haas-Kogan; Ellen J Bubrick; Patrick Y Wen; Ayal A Aizer
Journal:  Neurology       Date:  2021-01-05       Impact factor: 9.910

5.  Treatment Patterns and Outcomes of Women with Symptomatic and Asymptomatic Breast Cancer Brain Metastases: A Single-Center Retrospective Study.

Authors:  Yizhuo Kelly Gao; Markus Kuksis; Badr Id Said; Rania Chehade; Alex Kiss; William Tran; Faisal Sickandar; Arjun Sahgal; Ellen Warner; Hany Soliman; Katarzyna J Jerzak
Journal:  Oncologist       Date:  2021-09-21

6.  Prognosis of patients treated in a single neurosurgical reference centre for brain metastasis caused by dormant disseminated cells.

Authors:  Lorenzo Ferlini; Lorenzo Peluso; Valentina Lolli; Nicolas Gaspard; Florence Lefranc
Journal:  Oncol Lett       Date:  2021-04-08       Impact factor: 2.967

7.  Value of screening and follow-up brain MRI scans in patients with metastatic melanoma.

Authors:  Annemarie C Eggen; Thijs T Wind; Ingeborg Bosma; Miranda C A Kramer; Peter Jan van Laar; Hiska L van der Weide; Geke A P Hospers; Mathilde Jalving
Journal:  Cancer Med       Date:  2021-11-05       Impact factor: 4.452

8.  Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation.

Authors:  Laurence Mengue; Aurélie Bertaut; Louise Ngo Mbus; Mélanie Doré; Myriam Ayadi; Karen Clément-Colmou; Line Claude; Christian Carrie; Cécile Laude; Ronan Tanguy; Julie Blanc; Marie-Pierre Sunyach
Journal:  Radiat Oncol       Date:  2020-04-17       Impact factor: 3.481

Review 9.  Pathologically confirmed brain metastases from primary uterine cervical tumors: two cases and a literature review.

Authors:  Yalan Bi; Lei Li
Journal:  World J Surg Oncol       Date:  2019-10-31       Impact factor: 2.754

10.  Clinical and genetic factors associated with anxiety and depression in breast cancer patients: a cross-sectional study.

Authors:  Aline Hajj; Roula Hachem; Rita Khoury; Souheil Hallit; Bashar ElJEBBAWI; Fady Nasr; Fadi El Karak; Georges Chahine; Joseph Kattan; Lydia Rabbaa Khabbaz
Journal:  BMC Cancer       Date:  2021-07-30       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.